Αποτελέσματα Αναζήτησης
29 Μαΐ 2018 · Results. Among thyroid cancer survivors, age and year at cancer diagnosis, cancer stage, sex, baseline body mass index, baseline comorbidities, and TSH suppression therapy were significantly associated with CVD risk 1 to 5 years after cancer diagnosis.
25 Ιαν 2019 · Cancer patients who experienced tachycardia within one year of cancer diagnosis had higher mortality rates up to 10 years after diagnosis of tachycardia, according to research presented at the American College of Cardiology's Advancing the Cardiovascular Care of the Oncology Patient conference.
10 Αυγ 2017 · Studies using Holter monitoring have shown an association between anthracycline administration and a broad range of arrhythmias, including sinus bradycardia and tachycardia, premature atrial complexes, supraventricular tachycardia (SVT), premature ventricular complexes (PVCs), and ventricular tachycardia (VT).
2 Νοε 2022 · The patients had persistent higher CHD risk for 5 years after cancer diagnosis. Thyroid cancer survivors have a substantial CHD risk, even at long-term follow-up, especially in those patients <...
29 Νοε 2021 · The use of suppressive doses of levothyroxine in patients after thyroidectomy for differentiated thyroid carcinoma does not significantly increase the risk of supraventricular or ventricular extrasystoles, or paroxysmal supraventricular tachycardia.
10 Δεκ 2019 · The association between thyroid dysfunction and supraventricular tachyarrhythmia (SVT) other than atrial fibrillation (AF) is not well elucidated. We hypothesized that patients with suspected or documented SVT have undetected thyroid dysfunction more frequently than general population.
31 Αυγ 2019 · The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC): Developed in collaboration with the Association for European Paediatric and Congenital Cardiology (AEPC) ...
